Trifluridine
CAS No. 70-00-8
Trifluridine ( NSC 75520 | NSC 529182 | TFT | Trifluridine )
产品货号. M15687 CAS No. 70-00-8
三氟胸苷 (TFT) 是胸苷磷酸化酶的抑制剂。
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 50MG | ¥117 | 有现货 |
|
| 100MG | ¥197 | 有现货 |
|
| 500MG | 获取报价 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
| 1 mL x 10 mM in DMSO | ¥131 | 有现货 |
|
生物学信息
-
产品名称Trifluridine
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述三氟胸苷 (TFT) 是胸苷磷酸化酶的抑制剂。
-
产品描述Trifluorothymidine (TFT) and is an inhibitor of thymidine phosphorylase. TFT also inhibits thymidylate synthase (TS), a rate-limiting enzyme of DNA biosynthesis, and is incorporated into DNA.
-
体外实验Cell Viability Assay Cell Line:HUVEC cellsConcentration: 0-5 μM Incubation Time:3 days Result:Cell viability dropped sharply at 3 μM and 5 μM.Immunofluorescence Cell Line:HUVEC cells Concentration: 0-5 μM Incubation Time:3 days Result:Induced cellular senescence by inhibiting autophagy flux.Western Blot Analysis Cell Line:HUVEC cells Concentration: 0-5 μM Incubation Time:3 daysResult:Increased protein levels of senescence markers: p53, p16, SASP (IL-1, IL-6, TNF-α, p21).Cell Proliferation AssayCell Line:MCF-7, MDA-MB-231, BT-549, Hs578T and MCF-10A(control non-tumor) cells Concentration:5 μM-20 μM Incubation Time:24 h–72 h Result:Inhibited the proliferation of MDA-MB231, BT549 and Hs578T cells at 10μM and 20μM, significantly.Apoptosis AnalysisCell Line: MDA-MB-231, BT-549, and Hs578T cells Concentration:10μM or 20 μMIncubation Time:48 h Result:Increased the percentages of apoptotic TNBC cells (MDA-MB-231, BT-549, and Hs578Tcells) at 10μM and 20μM, significantly.
-
体内实验Animal Model:Nude mice (human colorectal intraperitoneal xenograft model) Dosage: 200 mg/kg(trifluridine/tipiracil)Administration:Oral administration; Once a day; 5 days followed by 2 drug-free days, a total of 6 weeks Result:Exhibited a significantly longer survival time compared with untreated mice.Animal Model:Mouse model of breast cancerDosage:75 or 150 mg/kg Administration:Oral gavage; daily for 10 days Result:Treatment with different doses inhibited the growth of TNBC tumors in mouse in a dose-dependent mannerAnimal Model:The human gastric MKN45 intraperitoneal xenograft model Dosage:200 mg/kg (Trifluridine/tipiracil)Administration:twice daily for 5 consecutive days followed by 2 drug?free days for 6 weeks Result:Prolonged the survival of mice compared with untreated mice.
-
同义词NSC 75520 | NSC 529182 | TFT | Trifluridine
-
通路Cell Cycle/DNA Damage
-
靶点DNA/RNA Synthesis
-
受体DNA/RNA Synthesis| Thymidylate synthase
-
研究领域Cancer
-
适应症——
化学信息
-
CAS Number70-00-8
-
分子量296.2
-
分子式C10H11F3N2O5
-
纯度>98% (HPLC)
-
溶解度Ethanol: 59 mg/mL (199.18 mM); Water: 59 mg/mL (199.18 mM); DMSO: 59 mg/mL (199.18 mM)
-
SMILESO=C1NC(C(C(F)(F)F)=CN1[C@@H]2O[C@H](CO)[C@@H](O)C2)=O
-
化学全称1-((2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-5-(trifluoromethyl)pyrimidine-2,4(1H,3H)-dione.
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1.Shintani M, et al. Oncol Rep. 2010 May; 23(5):1345-50.
产品手册
关联产品
-
AVG-233
AVG-233 是一种口服有效的 RNA 依赖性 RNA 聚合酶 (RdRp) 抑制剂。AVG-233 阻止启动子上的病毒聚合酶复合物的启动。AVG-233 结合位点存在于 L1-1749 片段中。AVG-233 对 RSV 毒株和临床分离株均具有纳摩尔活性 (EC50=0.14-0.31 μM)。AVG-233 可用于呼吸道合胞病毒 (RSV) 研究。
-
TH-588
一种有效的选择性 MTH1 蛋白抑制剂,IC50 为 5 nM。
-
Ddr1-In-1
DDR1-IN-1 是一种有效且特异性的 DDR1 受体酪氨酸激酶抑制剂 (IC50: 105 nM),选择性约为 DDR2 的 3 倍。
021-51111890
购物车()
sales@molnova.cn

